Filing Details

Accession Number:
0001140361-12-018137
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-29 17:57:52
Reporting Period:
2012-03-27
Filing Date:
2012-03-29
Accepted Time:
2012-03-29 16:57:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1280753 M Heather Bresch 1500 Corporate Drive
Canonsburg PA 15317
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-27 7,075 $0.00 147,445 No 4 M Direct
Common Stock Disposition 2012-03-27 2,961 $23.35 144,484 No 4 F Direct
Common Stock Acquisiton 2012-03-27 49,528 $0.00 194,012 No 4 M Direct
Common Stock Disposition 2012-03-27 20,723 $23.35 173,289 No 4 F Direct
Common Stock Acquisiton 2012-03-28 197,306 $11.18 370,595 No 4 M Direct
Common Stock Disposition 2012-03-28 197,306 $23.14 173,289 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2012-03-27 7,075 $0.00 7,075 $0.00
Common Stock Restricted Stock Units Acquisiton 2012-03-27 49,528 $0.00 49,528 $0.00
Common Stock Stock Option Right to Buy Acquisiton 2012-03-28 197,306 $0.00 197,306 $11.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
0 No 4 M Direct
0 2011-03-18 2018-03-18 No 4 M Direct
Footnotes
  1. The reporting person's indirect ownership through 401(k) holdings as of March 29, 2012 was 1,157 shares.
  2. Represents withholding of shares for the tax liability associated with the vesting of a portion of the restricted stock units (RSUs) granted on March 27, 2009.
  3. Represents withholding of shares for the tax liability associated with the vesting of the performance RSUs granted on March 27, 2009.
  4. Represents the weighted price of the reporting person's disposition, pursuant to the trading plan described below, of 197,306 shares in transactions ranging from $22.94 to $23.30.
  5. Each RSU represents the right to receive one share of Mylan Inc. common stock. Each of these awards vested fully on March 27, 2012.
  6. This option exercise and the related sale were executed pursuant to a 10b5-1 trading plan dated March 15, 2012.